Critical Care Medicine, ISSN 0090-3493, 03/2005, Volume 33, Issue 3, pp. 564 - 573
OBJECTIVE:To study the systemic release and kinetics of high mobility group box-1 protein (HMGB1) in relation to clinical features in a population of patients...
Septic shock | Sepsis-related Organ Failure Assessment score | Inflammation | High mobility group box-1 protein | Severe sepsis | Cytokine | cytokine | septic shock | EFFICACY | severe sepsis | SAFETY | MONOCLONAL-ANTIBODY | ORGAN FAILURE | AMPHOTERIN | THERAPY | NEURITE OUTGROWTH | inflammation | high mobility group box-1 protein | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | EPIDEMIOLOGY | CRITICAL CARE MEDICINE | Sepsis - immunology | Prospective Studies | Health Status Indicators | Humans | Male | Shock, Septic - immunology | Shock, Septic - mortality | Sweden - epidemiology | Case-Control Studies | Shock, Septic - metabolism | Sepsis - mortality | Inflammation - metabolism | Sepsis - metabolism | HMGB1 Protein - metabolism | Biomarkers | Female | Cytokines - blood
Septic shock | Sepsis-related Organ Failure Assessment score | Inflammation | High mobility group box-1 protein | Severe sepsis | Cytokine | cytokine | septic shock | EFFICACY | severe sepsis | SAFETY | MONOCLONAL-ANTIBODY | ORGAN FAILURE | AMPHOTERIN | THERAPY | NEURITE OUTGROWTH | inflammation | high mobility group box-1 protein | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | EPIDEMIOLOGY | CRITICAL CARE MEDICINE | Sepsis - immunology | Prospective Studies | Health Status Indicators | Humans | Male | Shock, Septic - immunology | Shock, Septic - mortality | Sweden - epidemiology | Case-Control Studies | Shock, Septic - metabolism | Sepsis - mortality | Inflammation - metabolism | Sepsis - metabolism | HMGB1 Protein - metabolism | Biomarkers | Female | Cytokines - blood
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 12239 - 11
Dendritic cell (DC) can be stimulated by both exogenous pathogen-associated molecular patterns (PAMPs) such as lipopolysaccharide (LPS) and endogenous...
MIRNA EXPRESSION | IMMUNITY | NECROTIC CELLS | C VIRUS-RNA | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | MIR-181 | HMGB1 | MICRORNAS | SEPSIS | TRANSLATION | Animals | Microarray Analysis | HMGB1 Protein - metabolism | Mice, Inbred C57BL | Cells, Cultured | Gene Expression Regulation | Dendritic Cells - physiology | MicroRNAs - metabolism | Cell Differentiation | Gene Expression Profiling | RNA, Messenger - metabolism | Tumor Necrosis Factor-alpha - biosynthesis | Post-transcription | Immune response | Dendritic cells | Transcription | MiRNA | Mobility | Tumor necrosis factor-α | HMGB1 protein | Lipopolysaccharides | High mobility group proteins | DNA microarrays | 3' Untranslated regions | Computer applications | Sepsis
MIRNA EXPRESSION | IMMUNITY | NECROTIC CELLS | C VIRUS-RNA | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | MIR-181 | HMGB1 | MICRORNAS | SEPSIS | TRANSLATION | Animals | Microarray Analysis | HMGB1 Protein - metabolism | Mice, Inbred C57BL | Cells, Cultured | Gene Expression Regulation | Dendritic Cells - physiology | MicroRNAs - metabolism | Cell Differentiation | Gene Expression Profiling | RNA, Messenger - metabolism | Tumor Necrosis Factor-alpha - biosynthesis | Post-transcription | Immune response | Dendritic cells | Transcription | MiRNA | Mobility | Tumor necrosis factor-α | HMGB1 protein | Lipopolysaccharides | High mobility group proteins | DNA microarrays | 3' Untranslated regions | Computer applications | Sepsis
Journal Article
BioMed research international, ISSN 2314-6133, 2019, Volume 2019, pp. 5190178 - 1
[This retracts the article DOI: 10.1155/2015/430185.].
Alternative medicine | Chromosomal proteins | Pancreatitis | Serum levels | Proteins | High mobility group proteins | Meta-analysis
Alternative medicine | Chromosomal proteins | Pancreatitis | Serum levels | Proteins | High mobility group proteins | Meta-analysis
Journal Article
International Archives of Allergy and Immunology, ISSN 1018-2438, 05/2013, Volume 161, Issue 2, pp. 116 - 121
Background: Allergic rhinitis (AR) is characterized by an inflammatory reaction. High-mobility group box-1 protein (HMGB1) has many characteristics similar to...
Original Paper | Nasal lavage | Allergic rhinitis | High-mobility group box-1 protein | CELLS | CROSSROADS | MEDIATOR | RECEPTOR | PROLIFERATION | HMGB1 | IMMUNOLOGY | ALLERGY | INFLAMMATION | ASTHMA | DIFFERENTIATION | GLYCATION END-PRODUCTS | HMGB1 Protein - analysis | Humans | Nasal Lavage Fluid - chemistry | Male | HMGB1 Protein - immunology | Inflammation - immunology | Eosinophils - immunology | Immunoglobulin E - blood | Rhinitis, Allergic, Seasonal - immunology | Adolescent | Nasal Lavage Fluid - immunology | Female | Child | Proteins | Allergies | Children & youth
Original Paper | Nasal lavage | Allergic rhinitis | High-mobility group box-1 protein | CELLS | CROSSROADS | MEDIATOR | RECEPTOR | PROLIFERATION | HMGB1 | IMMUNOLOGY | ALLERGY | INFLAMMATION | ASTHMA | DIFFERENTIATION | GLYCATION END-PRODUCTS | HMGB1 Protein - analysis | Humans | Nasal Lavage Fluid - chemistry | Male | HMGB1 Protein - immunology | Inflammation - immunology | Eosinophils - immunology | Immunoglobulin E - blood | Rhinitis, Allergic, Seasonal - immunology | Adolescent | Nasal Lavage Fluid - immunology | Female | Child | Proteins | Allergies | Children & youth
Journal Article
Scientific reports, ISSN 2045-2322, 10/2015, Volume 5, Issue 1, p. 15503
Excessive release of high mobility group box-1 (HMGB1) protein from ischemic cardiomyocytes activates inflammatory cascades and enhances myocardial injury...
MULTIDISCIPLINARY SCIENCES | Myocardial Ischemia - prevention & control | Mice | Animals | Reperfusion Injury - prevention & control | Electroacupuncture | HMGB1 Protein - physiology | Neonates | vagotomy | Mobility | Myocardial ischemia | Cardiomyocytes | Inflammation | Sympathetic nervous system | HMGB1 protein | Cholinesterase | High mobility group proteins | Neostigmine | Reperfusion | Ischemia | Rodents | Hypoxia | Norepinephrine | Acupuncture | Vagus nerve | Heart diseases
MULTIDISCIPLINARY SCIENCES | Myocardial Ischemia - prevention & control | Mice | Animals | Reperfusion Injury - prevention & control | Electroacupuncture | HMGB1 Protein - physiology | Neonates | vagotomy | Mobility | Myocardial ischemia | Cardiomyocytes | Inflammation | Sympathetic nervous system | HMGB1 protein | Cholinesterase | High mobility group proteins | Neostigmine | Reperfusion | Ischemia | Rodents | Hypoxia | Norepinephrine | Acupuncture | Vagus nerve | Heart diseases
Journal Article
Journal of International Medical Research, ISSN 0300-0605, 3/2019, Volume 47, Issue 3, pp. 1232 - 1240
Objective To investigate the relationship between serum high mobility group box-1 protein (HMGB-1) levels and prognosis in patients with community-acquired...
MEDICINE, RESEARCH & EXPERIMENTAL | C-reactive protein | INFLAMMATORY RESPONSES | RISK | CIRCULATING LEVEL | HMGB1 | High mobility group box-1 protein | community-acquired pneumonia | prognosis | ECONOMIC BURDEN | PREDICTION | BIOMARKERS | cortisol | clinical outcome | PHARMACOLOGY & PHARMACY | TERM MORTALITY | Proteins | Pneumonia | Hormones | Mortality | Clinical Research Reports
MEDICINE, RESEARCH & EXPERIMENTAL | C-reactive protein | INFLAMMATORY RESPONSES | RISK | CIRCULATING LEVEL | HMGB1 | High mobility group box-1 protein | community-acquired pneumonia | prognosis | ECONOMIC BURDEN | PREDICTION | BIOMARKERS | cortisol | clinical outcome | PHARMACOLOGY & PHARMACY | TERM MORTALITY | Proteins | Pneumonia | Hormones | Mortality | Clinical Research Reports
Journal Article
AIDS, ISSN 0269-9370, 07/2010, Volume 24, Issue 11, pp. 1733 - 1737
Objective: To investigate plasma levels of high mobility group box-1 protein (HMGB1), a marker of tissue necrosis and immune activation, as well as...
HIV-1 | microbial translocation | lipopolysaccharide | antiretroviral therapy | high mobility group box-1 protein | immune activation | INFECTIOUS DISEASES | VIROLOGY | ALPHA | HMGB1 | IMMUNOLOGY | HUMAN MONOCYTES | HIV Infections - blood | Virus Replication - drug effects | HIV Infections - virology | Humans | Male | RNA, Viral - blood | CD4 Lymphocyte Count | Biomarkers - blood | Viremia - drug therapy | HIV-1 - genetics | Disease Progression | Viral Load | HIV Infections - immunology | Lipopolysaccharides - blood | HIV-1 - physiology | Viremia - virology | HIV-1 - isolation & purification | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Retrospective Studies | Viremia - blood | HMGB1 Protein - blood | Basic Medicine | Immunologi | Medical and Health Sciences | Medicin och hälsovetenskap | Infektionsmedicin | Immunologi inom det medicinska området | Klinisk medicin | antiretroviral therapy; high mobility group box-1 protein; HIV-1; immune activation; lipopolysaccharide; microbial translocation | Clinical Medicine | Immunology | Infektionssjukdomar | Medicinska och farmaceutiska grundvetenskaper | Infectious Medicine | Infectious Diseases | Immunology in the medical area
HIV-1 | microbial translocation | lipopolysaccharide | antiretroviral therapy | high mobility group box-1 protein | immune activation | INFECTIOUS DISEASES | VIROLOGY | ALPHA | HMGB1 | IMMUNOLOGY | HUMAN MONOCYTES | HIV Infections - blood | Virus Replication - drug effects | HIV Infections - virology | Humans | Male | RNA, Viral - blood | CD4 Lymphocyte Count | Biomarkers - blood | Viremia - drug therapy | HIV-1 - genetics | Disease Progression | Viral Load | HIV Infections - immunology | Lipopolysaccharides - blood | HIV-1 - physiology | Viremia - virology | HIV-1 - isolation & purification | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Retrospective Studies | Viremia - blood | HMGB1 Protein - blood | Basic Medicine | Immunologi | Medical and Health Sciences | Medicin och hälsovetenskap | Infektionsmedicin | Immunologi inom det medicinska området | Klinisk medicin | antiretroviral therapy; high mobility group box-1 protein; HIV-1; immune activation; lipopolysaccharide; microbial translocation | Clinical Medicine | Immunology | Infektionssjukdomar | Medicinska och farmaceutiska grundvetenskaper | Infectious Medicine | Infectious Diseases | Immunology in the medical area
Journal Article
Cytokine, ISSN 1043-4666, 02/2020, Volume 126, p. 154880
IL levels were correlated with the mRNA levels of HMGB1/TLR-4 from allergic rhinitis patients with the analysis of Spearman correlation. High mobility group...
Toll-like receptor (TLR)-4 | High-mobility group box-1 protein 1 (HMGB1) | Interleukins (ILs) | Allergic rhinitis (AR)
Toll-like receptor (TLR)-4 | High-mobility group box-1 protein 1 (HMGB1) | Interleukins (ILs) | Allergic rhinitis (AR)
Journal Article
9.
Full Text
The Role of High-Mobility Group Box-1 Protein in the Development of Diabetic Nephropathy
American Journal of Nephrology, ISSN 0250-8095, 06/2011, Volume 33, Issue 6, pp. 524 - 529
Background/Aims: The purpose of the experiment reported here was to assess the involvement of high-mobility group box-1 (HMGB1), receptor for advanced...
Original Report: Laboratory Investigation | Diabetic nephropathy | High-mobility group box-1 protein | Receptor for advanced glycation end products | Nuclear factor-κB | Nuclear factor-kappa B | TUBULOINTERSTITIAL INJURY | HUMAN HEALTH | RENAL-DISEASE | HMGB1 | RAGE | CHROMATIN PROTEIN | DIETARY AGES | TUBULAR EPITHELIAL-CELLS | UROLOGY & NEPHROLOGY | NF-KAPPA-B | GLYCATION END-PRODUCTS | Diabetic Nephropathies - etiology | Diabetic Nephropathies - metabolism | Rats | Male | NF-kappa B - metabolism | RNA, Messenger - metabolism | Rats, Sprague-Dawley | Kidney Function Tests | Kidney - metabolism | Animals | HMGB1 Protein - metabolism | Receptor for Advanced Glycation End Products | Receptors, Immunologic - metabolism
Original Report: Laboratory Investigation | Diabetic nephropathy | High-mobility group box-1 protein | Receptor for advanced glycation end products | Nuclear factor-κB | Nuclear factor-kappa B | TUBULOINTERSTITIAL INJURY | HUMAN HEALTH | RENAL-DISEASE | HMGB1 | RAGE | CHROMATIN PROTEIN | DIETARY AGES | TUBULAR EPITHELIAL-CELLS | UROLOGY & NEPHROLOGY | NF-KAPPA-B | GLYCATION END-PRODUCTS | Diabetic Nephropathies - etiology | Diabetic Nephropathies - metabolism | Rats | Male | NF-kappa B - metabolism | RNA, Messenger - metabolism | Rats, Sprague-Dawley | Kidney Function Tests | Kidney - metabolism | Animals | HMGB1 Protein - metabolism | Receptor for Advanced Glycation End Products | Receptors, Immunologic - metabolism
Journal Article
Diabetes, ISSN 0012-1797, 06/2010, Volume 59, Issue 6, pp. 1496 - 1505
OBJECTIVE-High-mobility group box-1 (HMGB1) protein is a nuclear DNA-binding protein released from necrotic cells, inducing inflammatory responses and...
CELLS | HIGH-MOBILITY-GROUP-BOX-1 PROTEIN | ENDOCRINOLOGY & METABOLISM | HINDLIMB ISCHEMIA | TISSUE-DAMAGE | RECEPTOR | TUMOR ANGIOGENESIS | END-PRODUCTS RAGE | CORONARY-ARTERY-DISEASE | RAT MODEL | ENDOTHELIAL GROWTH-FACTOR | Neovascularization, Physiologic - genetics | Humans | Mice, Inbred C57BL | Diabetes Mellitus, Experimental - genetics | Male | Ischemia - physiopathology | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Vascular Endothelial Growth Factor A - genetics | HMGB1 Protein - genetics | Ischemia - prevention & control | Animals | Hindlimb - blood supply | Blood Flow Velocity | Diabetes Mellitus, Experimental - pathology | Neovascularization, Pathologic - genetics | Mice | Diabetes Mellitus, Experimental - metabolism | HMGB1 Protein - physiology | Muscle, Skeletal - blood supply | Complications and side effects | Ischemia | Physiological aspects | Genetic aspects | Research | DNA binding proteins | Diabetes | Neovascularization | Vascular endothelial growth factor | Original
CELLS | HIGH-MOBILITY-GROUP-BOX-1 PROTEIN | ENDOCRINOLOGY & METABOLISM | HINDLIMB ISCHEMIA | TISSUE-DAMAGE | RECEPTOR | TUMOR ANGIOGENESIS | END-PRODUCTS RAGE | CORONARY-ARTERY-DISEASE | RAT MODEL | ENDOTHELIAL GROWTH-FACTOR | Neovascularization, Physiologic - genetics | Humans | Mice, Inbred C57BL | Diabetes Mellitus, Experimental - genetics | Male | Ischemia - physiopathology | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Vascular Endothelial Growth Factor A - genetics | HMGB1 Protein - genetics | Ischemia - prevention & control | Animals | Hindlimb - blood supply | Blood Flow Velocity | Diabetes Mellitus, Experimental - pathology | Neovascularization, Pathologic - genetics | Mice | Diabetes Mellitus, Experimental - metabolism | HMGB1 Protein - physiology | Muscle, Skeletal - blood supply | Complications and side effects | Ischemia | Physiological aspects | Genetic aspects | Research | DNA binding proteins | Diabetes | Neovascularization | Vascular endothelial growth factor | Original
Journal Article
Forensic Science International, ISSN 0379-0738, 2014, Volume 239, pp. 103 - 106
Abstract The aims of this study were to assess whether high-mobility group box-1 protein can be determined in biological fluids collected during autopsy and...
Pathology | Sepsis | High-mobility group box-1 protein | Forensic pathology | Postmortem biochemistry | MEDICINE, LEGAL | HMGB1 | PLASMODIUM-FALCIPARUM MALARIA | PLASMA-CONCENTRATIONS | DISSEMINATED INTRAVASCULAR COAGULATION | HIGH-MOBILITY-GROUP-BOX-1 | TOLL-LIKE RECEPTORS | SEPTIC SHOCK | ORGAN DYSFUNCTION | GLYCATION END-PRODUCTS | SEVERE SEPSIS | Biomarkers - metabolism | Prospective Studies | Humans | Middle Aged | Sepsis - diagnosis | Male | Pericardium - metabolism | Case-Control Studies | Young Adult | HMGB1 Protein - metabolism | Adult | Female | Forensic Pathology | Aged | Postmortem Changes | Ubiquitin | Research | Autopsy | Methods | Studies | Dilution | Intensive care | Fatalities | Hospitalization | Calibration | Age | Proteins | Fluids | Autopsies | Fluid dynamics | Fluid flow | Death | Diagnostic systems | Serums
Pathology | Sepsis | High-mobility group box-1 protein | Forensic pathology | Postmortem biochemistry | MEDICINE, LEGAL | HMGB1 | PLASMODIUM-FALCIPARUM MALARIA | PLASMA-CONCENTRATIONS | DISSEMINATED INTRAVASCULAR COAGULATION | HIGH-MOBILITY-GROUP-BOX-1 | TOLL-LIKE RECEPTORS | SEPTIC SHOCK | ORGAN DYSFUNCTION | GLYCATION END-PRODUCTS | SEVERE SEPSIS | Biomarkers - metabolism | Prospective Studies | Humans | Middle Aged | Sepsis - diagnosis | Male | Pericardium - metabolism | Case-Control Studies | Young Adult | HMGB1 Protein - metabolism | Adult | Female | Forensic Pathology | Aged | Postmortem Changes | Ubiquitin | Research | Autopsy | Methods | Studies | Dilution | Intensive care | Fatalities | Hospitalization | Calibration | Age | Proteins | Fluids | Autopsies | Fluid dynamics | Fluid flow | Death | Diagnostic systems | Serums
Journal Article
世界胃肠病学杂志:英文版, ISSN 1007-9327, 2006, Volume 12, Issue 47, pp. 7666 - 7670
AIM: To examine the effects of anti-high mobility group box 1 (HIGB1) neutralizing antibody in experimental severe acute pancreatitis (SAP). METHODS: SAP was...
急性胰腺炎 | 丙胺酸 | 细菌易位 | 十二指肠 | Inflammatory response | Severe acute pancreatitis | High mobility group box-1 | Organ dysfunction | Bacterial translocation | Neutralizing antibody | NERVOUS-SYSTEM | 1 HMGB1 | MEDIATOR | inflammatory response | neutralizing antibody | LUNG INJURY | RECEPTOR | high mobility group box-1 | ORGAN FAILURE | SEPSIS | organ dysfunction | PROINFLAMMATORY CYTOKINE | severe acute pancreatitis | bacterial translocation | END-PRODUCTS RAGE | HMG-1 | GASTROENTEROLOGY & HEPATOLOGY | Antibodies - pharmacology | Severity of Illness Index | Immunotherapy - methods | Animals | Pancreatitis - therapy | Pancreatitis - immunology | Female | Pancreatitis - pathology | HMGB1 Protein - immunology | Mice | HMGB1 Protein - antagonists & inhibitors | Mice, Inbred C3H | Rapid Communication
急性胰腺炎 | 丙胺酸 | 细菌易位 | 十二指肠 | Inflammatory response | Severe acute pancreatitis | High mobility group box-1 | Organ dysfunction | Bacterial translocation | Neutralizing antibody | NERVOUS-SYSTEM | 1 HMGB1 | MEDIATOR | inflammatory response | neutralizing antibody | LUNG INJURY | RECEPTOR | high mobility group box-1 | ORGAN FAILURE | SEPSIS | organ dysfunction | PROINFLAMMATORY CYTOKINE | severe acute pancreatitis | bacterial translocation | END-PRODUCTS RAGE | HMG-1 | GASTROENTEROLOGY & HEPATOLOGY | Antibodies - pharmacology | Severity of Illness Index | Immunotherapy - methods | Animals | Pancreatitis - therapy | Pancreatitis - immunology | Female | Pancreatitis - pathology | HMGB1 Protein - immunology | Mice | HMGB1 Protein - antagonists & inhibitors | Mice, Inbred C3H | Rapid Communication
Journal Article
Cytokine, ISSN 1043-4666, 2011, Volume 54, Issue 3, pp. 296 - 304
High mobility group box-1 protein (HMGB1), a recently recognized mediator of immune response might contribute to immune suppression when released...
Cytotoxic T lymphocyte-associated antigen | High mobility group box-1 protein | Regulatory T cells | Forkhead/winged helix transcription factor p3 | Toll-like receptor | APOPTOSIS | ACTIVATION | DENDRITIC CELLS | THERMAL-INJURY | BIOCHEMISTRY & MOLECULAR BIOLOGY | SEPSIS | INDUCTION | IMMUNOLOGY | FOXP3 | CELL BIOLOGY | SUPPRESSIVE CAPACITY | LIPOPOLYSACCHARIDE | Forkhead/winged helix transcription factor P3 | PROMOTE | T-Lymphocytes, Regulatory - metabolism | Down-Regulation | CD4-Positive T-Lymphocytes - metabolism | Interleukin-2 Receptor alpha Subunit - biosynthesis | Toll-Like Receptor 4 - metabolism | Mice, Inbred C3H | Immunosuppression | Phenotype | Animals | Forkhead Transcription Factors - metabolism | HMGB1 Protein - metabolism | Interleukin-10 - metabolism | Mice | Mutation | Immunosuppressive Agents - pharmacology | Antigens | Chromosomal proteins | Analysis | Immunotherapy | Fluorescein | T cells | Mitogens | Enzyme-linked immunosorbent assay
Cytotoxic T lymphocyte-associated antigen | High mobility group box-1 protein | Regulatory T cells | Forkhead/winged helix transcription factor p3 | Toll-like receptor | APOPTOSIS | ACTIVATION | DENDRITIC CELLS | THERMAL-INJURY | BIOCHEMISTRY & MOLECULAR BIOLOGY | SEPSIS | INDUCTION | IMMUNOLOGY | FOXP3 | CELL BIOLOGY | SUPPRESSIVE CAPACITY | LIPOPOLYSACCHARIDE | Forkhead/winged helix transcription factor P3 | PROMOTE | T-Lymphocytes, Regulatory - metabolism | Down-Regulation | CD4-Positive T-Lymphocytes - metabolism | Interleukin-2 Receptor alpha Subunit - biosynthesis | Toll-Like Receptor 4 - metabolism | Mice, Inbred C3H | Immunosuppression | Phenotype | Animals | Forkhead Transcription Factors - metabolism | HMGB1 Protein - metabolism | Interleukin-10 - metabolism | Mice | Mutation | Immunosuppressive Agents - pharmacology | Antigens | Chromosomal proteins | Analysis | Immunotherapy | Fluorescein | T cells | Mitogens | Enzyme-linked immunosorbent assay
Journal Article
Frontiers in Immunology, ISSN 1664-3224, 02/2018, Volume 9, p. 268
Glutathione S-transferase Pi (GSTP) was originally identified as one of cytosolic phase II detoxification enzymes and also was considered to function via its...
Classic protein kinase C | Sepsis | Phosphorylation | High mobility group box-1 protein | Glutathione S-transferases P | CELLS | glutathione S-transferases P | ANTICANCER DRUG-RESISTANCE | KINASE-C | HMGB1 | IMMUNOLOGY | SITE-DIRECTED MUTAGENESIS | FACTOR RECEPTOR | NUCLEAR TRANSLOCATION | classic protein kinase C | INFLAMMATION | high mobility group box-1 protein | SEPTIC SHOCK | DOUBLE-BLIND | phosphorylation | sepsis | Cell Line | Glutathione S-Transferase pi - metabolism | Humans | Mice, Inbred C57BL | Male | Inflammation - immunology | Lipopolysaccharides - immunology | Mice, Knockout | Protein Transport | Animals | Protein Kinase C - metabolism | Sepsis - metabolism | HMGB1 Protein - metabolism | Mice | Macrophages - immunology | Disease Models, Animal | Glutathione S-Transferase pi - genetics | Glutathione transferase | Physiological aspects | Development and progression | Genetic aspects | Research | Macrophages
Classic protein kinase C | Sepsis | Phosphorylation | High mobility group box-1 protein | Glutathione S-transferases P | CELLS | glutathione S-transferases P | ANTICANCER DRUG-RESISTANCE | KINASE-C | HMGB1 | IMMUNOLOGY | SITE-DIRECTED MUTAGENESIS | FACTOR RECEPTOR | NUCLEAR TRANSLOCATION | classic protein kinase C | INFLAMMATION | high mobility group box-1 protein | SEPTIC SHOCK | DOUBLE-BLIND | phosphorylation | sepsis | Cell Line | Glutathione S-Transferase pi - metabolism | Humans | Mice, Inbred C57BL | Male | Inflammation - immunology | Lipopolysaccharides - immunology | Mice, Knockout | Protein Transport | Animals | Protein Kinase C - metabolism | Sepsis - metabolism | HMGB1 Protein - metabolism | Mice | Macrophages - immunology | Disease Models, Animal | Glutathione S-Transferase pi - genetics | Glutathione transferase | Physiological aspects | Development and progression | Genetic aspects | Research | Macrophages
Journal Article
Cellular Physiology and Biochemistry, ISSN 1015-8987, 04/2014, Volume 33, Issue 3, pp. 769 - 783
Background: High mobility group box-1 protein (HMGB1), a ubiquitous nuclear protein, which is recognized as a danger-associated molecular pattern (DAMP)...
Original Paper | High mobility group box-1 protein (HMGB1) | Jurkat T cells | Calcium | Mitofusin-2(Mfn2) | Apoptosis | MIGRATION | ACTIVATION | PHYSIOLOGY | DENDRITIC CELLS | TRIGGERS | DEATH | SEPSIS | HMGB1 | INFLAMMATION | ENDOPLASMIC-RETICULUM | DYSFUNCTION | Apoptosis - immunology | Caspases - immunology | Jurkat Cells | GTP Phosphohydrolases - immunology | Humans | Calcium Signaling - immunology | T-Lymphocytes - immunology | HMGB1 Protein - immunology | Mitochondrial Proteins - immunology
Original Paper | High mobility group box-1 protein (HMGB1) | Jurkat T cells | Calcium | Mitofusin-2(Mfn2) | Apoptosis | MIGRATION | ACTIVATION | PHYSIOLOGY | DENDRITIC CELLS | TRIGGERS | DEATH | SEPSIS | HMGB1 | INFLAMMATION | ENDOPLASMIC-RETICULUM | DYSFUNCTION | Apoptosis - immunology | Caspases - immunology | Jurkat Cells | GTP Phosphohydrolases - immunology | Humans | Calcium Signaling - immunology | T-Lymphocytes - immunology | HMGB1 Protein - immunology | Mitochondrial Proteins - immunology
Journal Article